7Baggers
 Plus Therapeutics Gains Nasdaq Extension for Compliance  TipRanks Mon, 17 Nov 2025 13:01:51 GMT
 Plus Therapeutics receives Nasdaq extension to meet minimum bid price  Investing.com Mon, 17 Nov 2025 12:54:31 GMT
 published on: 2025-11-10 07:13:12  newser.com Mon, 10 Nov 2025 13:13:12 GMT
 published on: 2025-11-09 12:06:55  newser.com Sun, 09 Nov 2025 18:06:55 GMT
 published on: 2025-11-07 01:50:38  newser.com Fri, 07 Nov 2025 07:50:38 GMT
 plus therapeutics to present cancer therapy data at upcoming summit  Investing.com Fri, 07 Nov 2025 00:59:58 GMT
 Plus Therapeutics Stock (PSTV) Opinions on UnitedHealthcare Coverage Agreement  Quiver Quantitative Thu, 06 Nov 2025 14:06:00 GMT
 plus therapeutics to present cancer therapy data at upcoming summit  Investing.com Thu, 06 Nov 2025 08:00:00 GMT
 Plus Therapeutics CFO Sims buys $10,200 in shares  Investing.com Wed, 05 Nov 2025 08:00:00 GMT
 published on: 2025-11-05 00:49:52  newser.com Wed, 05 Nov 2025 06:49:52 GMT
 plus therapeutics stock price target lowered to $2 at h.c. wainwright  Investing.com Australia Tue, 04 Nov 2025 11:33:38 GMT
 plus therapeutics shares face unrelenting decline  AD HOC NEWS Tue, 04 Nov 2025 09:25:04 GMT
 plus therapeutics (pstv) analyst rating update: price target low  GuruFocus Mon, 03 Nov 2025 12:11:50 GMT

Plus Therapeutics
(NASDAQ:PSTV) 

PSTV stock logo

Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system...

Founded: 1996
Full Time Employees: 14
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends